Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 1 |
2022 | 1 |
2024 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
CRISPR/Cas9-Mediated Allele-Specific Disruption of a Dominant COL6A1 Pathogenic Variant Improves Collagen VI Network in Patient Fibroblasts.
Int J Mol Sci. 2022 Apr 16;23(8):4410. doi: 10.3390/ijms23084410.
Int J Mol Sci. 2022.
PMID: 35457228
Free PMC article.
Therapeutic Potential of EWSR1-FLI1 Inactivation by CRISPR/Cas9 in Ewing Sarcoma.
Cervera ST, Rodríguez-Martín C, Fernández-Tabanera E, Melero-Fernández de Mera RM, Morin M, Fernández-Peñalver S, Iranzo-Martínez M, Amhih-Cardenas J, García-García L, González-González L, Moreno-Pelayo MA, Alonso J.
Cervera ST, et al.
Cancers (Basel). 2021 Jul 27;13(15):3783. doi: 10.3390/cancers13153783.
Cancers (Basel). 2021.
PMID: 34359682
Free PMC article.
Item in Clipboard
Cite
Cite